Jill A Greytok

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Pulmonary Fibrosis

Transcription Factor

Replacement Therapy

Top Venues

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen A Harrison, Patrick R Mayo, Todd M Hobbs, Carlos Canizares, Erin P Foster, Caroline Zhao, Daren R Ure, Daniel J Trepanier, Jill A Greytok, Robert T Foster
Rencofilstat, a cyclophilin inhibitor: A phase 2a, multicenter, single-blind, placebo-controlled study in F2/F3 NASH. Hepatology communications 6 (12) (2022)